Cost controls help offset lower Amgen first-quarter drug sales
Go back to Cost controls help offset lower Amgen first-quarter drug sales| Amgen Inc (NASDAQ: AMGN) | Delayed: 415.73 +0.52 (0.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $415.21 | 52 Week High | $176.85 | |||
| Open | $412.98 | 52 Week Low | $133.64 | |||
| Day High | $416.31 | P/E | 62.61 | |||
| Day Low | $410.40 | EPS | $6.64 | |||
| Volume | 104,594 | |||||

